09.03.25 -- What FDA's Complete Response Letters (CRL) Say About Outsourcing

Discover how Cambrex is advancing peptide manufacturing with innovative liquid phase peptide synthesis (LPPS) technology, reducing costs, environmental impact, and reliance on specialized reactors. Join experts Adrian Amador and David Wang for this live webinar exploring LPPS applications, regulatory considerations, impurity control, and analytical strategies. Register today to gain insights that can accelerate your peptide development programs. Click here to learn more.

Explore the exciting developments in continuous manufacturing, and learn how leveraging technology can help improve manufacturing processes and discover new clinical candidates.

Anshul Gupte Ph.D., RAC Drugs, VP of Pharmaceutical Development, shares about phase-appropriate development, technical hurdles, building agile teams, and planning strategy for novel therapies.

Discover the challenges associated with pH-dependent solubility for oral tyrosine kinase inhibitor drugs and how utilizing ASD formulation can help create more effective, patient-friendly drug products.

Operational readiness will separate the leaders from the laggards, whether you lead a pharma/biotech innovator, CDMO, or a combination of both.

Regulators are implementing new rules to combat counterfeit medicines. Learn how serialization, tamper-evident seals, and track-and-trace solutions protect products and patients from risk.

Industry 4.0 is revolutionizing CDMOs and CMOs. Find out how AI, IIoT, and automation are driving smarter, faster, and more compliant manufacturing to ensure agility, precision, and innovation.

The unique characteristics of softgel capsules can play a pivotal role in the success of a drug. By addressing stability and shelf-life challenges, softgels have become a valuable tool for manufacturers.

See how an innovative formulation platform reduced development timelines and allowed a sponsor to find the optimal nafamostat formulation without adding unnecessary delays.

Explore taste-masking solutions that can elevate your oral dosage forms, drive the success of your business, and address the needs of multiple, large patient populations.

Navigate the complexities of pharmaceutical formulation when development is a high-stakes, precision-driven science, especially for early-phase injectable drugs.

The right partner can leverage years of experience, market knowledge, industry relationships, and clinical packaging expertise to develop a sourcing strategy tailored to the needs of each study.

A highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.